Global Therapeutic Nuclear Medicines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 115
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Therapeutic Nuclear Medicines market size was valued at USD 1719.4 million in 2023 and is forecast to a readjusted size of USD 5230.4 million by 2030 with a CAGR of 17.2% during review period.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.
The Global Info Research report includes an overview of the development of the Therapeutic Nuclear Medicines industry chain, the market status of Thyroid (Radium-223, Lutetium-177), Bone Metastasis (Radium-223, Lutetium-177), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Therapeutic Nuclear Medicines.
Regionally, the report analyzes the Therapeutic Nuclear Medicines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Therapeutic Nuclear Medicines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Therapeutic Nuclear Medicines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Therapeutic Nuclear Medicines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Radium-223, Lutetium-177).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Therapeutic Nuclear Medicines market.
Regional Analysis: The report involves examining the Therapeutic Nuclear Medicines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Therapeutic Nuclear Medicines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Therapeutic Nuclear Medicines:
Company Analysis: Report covers individual Therapeutic Nuclear Medicines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Therapeutic Nuclear Medicines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Thyroid, Bone Metastasis).
Technology Analysis: Report covers specific technologies relevant to Therapeutic Nuclear Medicines. It assesses the current state, advancements, and potential future developments in Therapeutic Nuclear Medicines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Therapeutic Nuclear Medicines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Therapeutic Nuclear Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Market segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
Major players covered
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Nuclear Medicines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Therapeutic Nuclear Medicines, with price, sales, revenue and global market share of Therapeutic Nuclear Medicines from 2019 to 2024.
Chapter 3, the Therapeutic Nuclear Medicines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Nuclear Medicines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Therapeutic Nuclear Medicines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Therapeutic Nuclear Medicines.
Chapter 14 and 15, to describe Therapeutic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Therapeutic Nuclear Medicines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Radium-223
1.3.3 Lutetium-177
1.3.4 Iodine-131
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Therapeutic Nuclear Medicines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Thyroid
1.4.3 Bone Metastasis
1.4.4 Lymphoma
1.4.5 Other
1.5 Global Therapeutic Nuclear Medicines Market Size & Forecast
1.5.1 Global Therapeutic Nuclear Medicines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Therapeutic Nuclear Medicines Sales Quantity (2019-2030)
1.5.3 Global Therapeutic Nuclear Medicines Average Price (2019-2030)
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Therapeutic Nuclear Medicines Product and Services
2.1.4 Novartis AG Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Therapeutic Nuclear Medicines Product and Services
2.2.4 Bayer Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bayer Recent Developments/Updates
2.3 China Isotope & Radiation
2.3.1 China Isotope & Radiation Details
2.3.2 China Isotope & Radiation Major Business
2.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Product and Services
2.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 China Isotope & Radiation Recent Developments/Updates
2.4 Q BioMed
2.4.1 Q BioMed Details
2.4.2 Q BioMed Major Business
2.4.3 Q BioMed Therapeutic Nuclear Medicines Product and Services
2.4.4 Q BioMed Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Q BioMed Recent Developments/Updates
2.5 Curium Pharmaceuticals
2.5.1 Curium Pharmaceuticals Details
2.5.2 Curium Pharmaceuticals Major Business
2.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
2.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Curium Pharmaceuticals Recent Developments/Updates
2.6 Jubilant DraxImage
2.6.1 Jubilant DraxImage Details
2.6.2 Jubilant DraxImage Major Business
2.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Product and Services
2.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Jubilant DraxImage Recent Developments/Updates
2.7 Dongcheng
2.7.1 Dongcheng Details
2.7.2 Dongcheng Major Business
2.7.3 Dongcheng Therapeutic Nuclear Medicines Product and Services
2.7.4 Dongcheng Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Dongcheng Recent Developments/Updates
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business
2.8.3 Lantheus Therapeutic Nuclear Medicines Product and Services
2.8.4 Lantheus Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Lantheus Recent Developments/Updates
2.9 Acrotech Biopharma.
2.9.1 Acrotech Biopharma. Details
2.9.2 Acrotech Biopharma. Major Business
2.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Product and Services
2.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Acrotech Biopharma. Recent Developments/Updates
2.10 Progenics Pharmaceuticals
2.10.1 Progenics Pharmaceuticals Details
2.10.2 Progenics Pharmaceuticals Major Business
2.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
2.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Progenics Pharmaceuticals Recent Developments/Updates
2.11 International Isotopes
2.11.1 International Isotopes Details
2.11.2 International Isotopes Major Business
2.11.3 International Isotopes Therapeutic Nuclear Medicines Product and Services
2.11.4 International Isotopes Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 International Isotopes Recent Developments/Updates
3.1 Global Therapeutic Nuclear Medicines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2019-2024)
3.3 Global Therapeutic Nuclear Medicines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Therapeutic Nuclear Medicines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Therapeutic Nuclear Medicines Manufacturer Market Share in 2023
3.4.2 Top 6 Therapeutic Nuclear Medicines Manufacturer Market Share in 2023
3.5 Therapeutic Nuclear Medicines Market: Overall Company Footprint Analysis
3.5.1 Therapeutic Nuclear Medicines Market: Region Footprint
3.5.2 Therapeutic Nuclear Medicines Market: Company Product Type Footprint
3.5.3 Therapeutic Nuclear Medicines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Therapeutic Nuclear Medicines Market Size by Region
4.1.1 Global Therapeutic Nuclear Medicines Sales Quantity by Region (2019-2030)
4.1.2 Global Therapeutic Nuclear Medicines Consumption Value by Region (2019-2030)
4.1.3 Global Therapeutic Nuclear Medicines Average Price by Region (2019-2030)
4.2 North America Therapeutic Nuclear Medicines Consumption Value (2019-2030)
4.3 Europe Therapeutic Nuclear Medicines Consumption Value (2019-2030)
4.4 Asia-Pacific Therapeutic Nuclear Medicines Consumption Value (2019-2030)
4.5 South America Therapeutic Nuclear Medicines Consumption Value (2019-2030)
4.6 Middle East and Africa Therapeutic Nuclear Medicines Consumption Value (2019-2030)
5.1 Global Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2030)
5.2 Global Therapeutic Nuclear Medicines Consumption Value by Type (2019-2030)
5.3 Global Therapeutic Nuclear Medicines Average Price by Type (2019-2030)
6.1 Global Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2030)
6.2 Global Therapeutic Nuclear Medicines Consumption Value by Application (2019-2030)
6.3 Global Therapeutic Nuclear Medicines Average Price by Application (2019-2030)
7.1 North America Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2030)
7.2 North America Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2030)
7.3 North America Therapeutic Nuclear Medicines Market Size by Country
7.3.1 North America Therapeutic Nuclear Medicines Sales Quantity by Country (2019-2030)
7.3.2 North America Therapeutic Nuclear Medicines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2030)
8.2 Europe Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2030)
8.3 Europe Therapeutic Nuclear Medicines Market Size by Country
8.3.1 Europe Therapeutic Nuclear Medicines Sales Quantity by Country (2019-2030)
8.3.2 Europe Therapeutic Nuclear Medicines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Therapeutic Nuclear Medicines Market Size by Region
9.3.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Therapeutic Nuclear Medicines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2030)
10.2 South America Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2030)
10.3 South America Therapeutic Nuclear Medicines Market Size by Country
10.3.1 South America Therapeutic Nuclear Medicines Sales Quantity by Country (2019-2030)
10.3.2 South America Therapeutic Nuclear Medicines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Therapeutic Nuclear Medicines Market Size by Country
11.3.1 Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Therapeutic Nuclear Medicines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Therapeutic Nuclear Medicines Market Drivers
12.2 Therapeutic Nuclear Medicines Market Restraints
12.3 Therapeutic Nuclear Medicines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Therapeutic Nuclear Medicines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Therapeutic Nuclear Medicines
13.3 Therapeutic Nuclear Medicines Production Process
13.4 Therapeutic Nuclear Medicines Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Therapeutic Nuclear Medicines Typical Distributors
14.3 Therapeutic Nuclear Medicines Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Therapeutic Nuclear Medicines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Therapeutic Nuclear Medicines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Therapeutic Nuclear Medicines Product and Services
Table 6. Novartis AG Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Therapeutic Nuclear Medicines Product and Services
Table 11. Bayer Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bayer Recent Developments/Updates
Table 13. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 14. China Isotope & Radiation Major Business
Table 15. China Isotope & Radiation Therapeutic Nuclear Medicines Product and Services
Table 16. China Isotope & Radiation Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. China Isotope & Radiation Recent Developments/Updates
Table 18. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 19. Q BioMed Major Business
Table 20. Q BioMed Therapeutic Nuclear Medicines Product and Services
Table 21. Q BioMed Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Q BioMed Recent Developments/Updates
Table 23. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Curium Pharmaceuticals Major Business
Table 25. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 26. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Curium Pharmaceuticals Recent Developments/Updates
Table 28. Jubilant DraxImage Basic Information, Manufacturing Base and Competitors
Table 29. Jubilant DraxImage Major Business
Table 30. Jubilant DraxImage Therapeutic Nuclear Medicines Product and Services
Table 31. Jubilant DraxImage Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Jubilant DraxImage Recent Developments/Updates
Table 33. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 34. Dongcheng Major Business
Table 35. Dongcheng Therapeutic Nuclear Medicines Product and Services
Table 36. Dongcheng Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Dongcheng Recent Developments/Updates
Table 38. Lantheus Basic Information, Manufacturing Base and Competitors
Table 39. Lantheus Major Business
Table 40. Lantheus Therapeutic Nuclear Medicines Product and Services
Table 41. Lantheus Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Lantheus Recent Developments/Updates
Table 43. Acrotech Biopharma. Basic Information, Manufacturing Base and Competitors
Table 44. Acrotech Biopharma. Major Business
Table 45. Acrotech Biopharma. Therapeutic Nuclear Medicines Product and Services
Table 46. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Acrotech Biopharma. Recent Developments/Updates
Table 48. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Progenics Pharmaceuticals Major Business
Table 50. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 51. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Progenics Pharmaceuticals Recent Developments/Updates
Table 53. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 54. International Isotopes Major Business
Table 55. International Isotopes Therapeutic Nuclear Medicines Product and Services
Table 56. International Isotopes Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. International Isotopes Recent Developments/Updates
Table 58. Global Therapeutic Nuclear Medicines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Therapeutic Nuclear Medicines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 61. Market Position of Manufacturers in Therapeutic Nuclear Medicines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Therapeutic Nuclear Medicines Production Site of Key Manufacturer
Table 63. Therapeutic Nuclear Medicines Market: Company Product Type Footprint
Table 64. Therapeutic Nuclear Medicines Market: Company Product Application Footprint
Table 65. Therapeutic Nuclear Medicines New Market Entrants and Barriers to Market Entry
Table 66. Therapeutic Nuclear Medicines Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Therapeutic Nuclear Medicines Sales Quantity by Region (2019-2024) & (K Units)
Table 68. Global Therapeutic Nuclear Medicines Sales Quantity by Region (2025-2030) & (K Units)
Table 69. Global Therapeutic Nuclear Medicines Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Therapeutic Nuclear Medicines Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Therapeutic Nuclear Medicines Average Price by Region (2019-2024) & (USD/Unit)
Table 72. Global Therapeutic Nuclear Medicines Average Price by Region (2025-2030) & (USD/Unit)
Table 73. Global Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Global Therapeutic Nuclear Medicines Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Global Therapeutic Nuclear Medicines Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Therapeutic Nuclear Medicines Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Therapeutic Nuclear Medicines Average Price by Type (2019-2024) & (USD/Unit)
Table 78. Global Therapeutic Nuclear Medicines Average Price by Type (2025-2030) & (USD/Unit)
Table 79. Global Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Global Therapeutic Nuclear Medicines Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Global Therapeutic Nuclear Medicines Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Therapeutic Nuclear Medicines Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Therapeutic Nuclear Medicines Average Price by Application (2019-2024) & (USD/Unit)
Table 84. Global Therapeutic Nuclear Medicines Average Price by Application (2025-2030) & (USD/Unit)
Table 85. North America Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2024) & (K Units)
Table 86. North America Therapeutic Nuclear Medicines Sales Quantity by Type (2025-2030) & (K Units)
Table 87. North America Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2024) & (K Units)
Table 88. North America Therapeutic Nuclear Medicines Sales Quantity by Application (2025-2030) & (K Units)
Table 89. North America Therapeutic Nuclear Medicines Sales Quantity by Country (2019-2024) & (K Units)
Table 90. North America Therapeutic Nuclear Medicines Sales Quantity by Country (2025-2030) & (K Units)
Table 91. North America Therapeutic Nuclear Medicines Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Therapeutic Nuclear Medicines Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Europe Therapeutic Nuclear Medicines Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Europe Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2024) & (K Units)
Table 96. Europe Therapeutic Nuclear Medicines Sales Quantity by Application (2025-2030) & (K Units)
Table 97. Europe Therapeutic Nuclear Medicines Sales Quantity by Country (2019-2024) & (K Units)
Table 98. Europe Therapeutic Nuclear Medicines Sales Quantity by Country (2025-2030) & (K Units)
Table 99. Europe Therapeutic Nuclear Medicines Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Therapeutic Nuclear Medicines Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2024) & (K Units)
Table 102. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Type (2025-2030) & (K Units)
Table 103. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2024) & (K Units)
Table 104. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Application (2025-2030) & (K Units)
Table 105. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Region (2019-2024) & (K Units)
Table 106. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Region (2025-2030) & (K Units)
Table 107. Asia-Pacific Therapeutic Nuclear Medicines Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Therapeutic Nuclear Medicines Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2024) & (K Units)
Table 110. South America Therapeutic Nuclear Medicines Sales Quantity by Type (2025-2030) & (K Units)
Table 111. South America Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2024) & (K Units)
Table 112. South America Therapeutic Nuclear Medicines Sales Quantity by Application (2025-2030) & (K Units)
Table 113. South America Therapeutic Nuclear Medicines Sales Quantity by Country (2019-2024) & (K Units)
Table 114. South America Therapeutic Nuclear Medicines Sales Quantity by Country (2025-2030) & (K Units)
Table 115. South America Therapeutic Nuclear Medicines Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Therapeutic Nuclear Medicines Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Type (2019-2024) & (K Units)
Table 118. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Type (2025-2030) & (K Units)
Table 119. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Region (2019-2024) & (K Units)
Table 122. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Region (2025-2030) & (K Units)
Table 123. Middle East & Africa Therapeutic Nuclear Medicines Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Therapeutic Nuclear Medicines Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Therapeutic Nuclear Medicines Raw Material
Table 126. Key Manufacturers of Therapeutic Nuclear Medicines Raw Materials
Table 127. Therapeutic Nuclear Medicines Typical Distributors
Table 128. Therapeutic Nuclear Medicines Typical Customers
List of Figures
Figure 1. Therapeutic Nuclear Medicines Picture
Figure 2. Global Therapeutic Nuclear Medicines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Type in 2023
Figure 4. Radium-223 Examples
Figure 5. Lutetium-177 Examples
Figure 6. Iodine-131 Examples
Figure 7. Other Examples
Figure 8. Global Therapeutic Nuclear Medicines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Application in 2023
Figure 10. Thyroid Examples
Figure 11. Bone Metastasis Examples
Figure 12. Lymphoma Examples
Figure 13. Other Examples
Figure 14. Global Therapeutic Nuclear Medicines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Therapeutic Nuclear Medicines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Therapeutic Nuclear Medicines Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Therapeutic Nuclear Medicines Average Price (2019-2030) & (USD/Unit)
Figure 18. Global Therapeutic Nuclear Medicines Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Therapeutic Nuclear Medicines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Therapeutic Nuclear Medicines Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Therapeutic Nuclear Medicines Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Therapeutic Nuclear Medicines Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Therapeutic Nuclear Medicines Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Therapeutic Nuclear Medicines Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Therapeutic Nuclear Medicines Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Therapeutic Nuclear Medicines Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Therapeutic Nuclear Medicines Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Therapeutic Nuclear Medicines Average Price by Type (2019-2030) & (USD/Unit)
Figure 33. Global Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Therapeutic Nuclear Medicines Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Therapeutic Nuclear Medicines Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Therapeutic Nuclear Medicines Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Therapeutic Nuclear Medicines Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Therapeutic Nuclear Medicines Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Therapeutic Nuclear Medicines Consumption Value Market Share by Region (2019-2030)
Figure 56. China Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Therapeutic Nuclear Medicines Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Therapeutic Nuclear Medicines Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Therapeutic Nuclear Medicines Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Therapeutic Nuclear Medicines Market Drivers
Figure 77. Therapeutic Nuclear Medicines Market Restraints
Figure 78. Therapeutic Nuclear Medicines Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines in 2023
Figure 81. Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure 82. Therapeutic Nuclear Medicines Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis AG Bayer China Isotope & Radiation Q BioMed Curium Pharmaceuticals Jubilant DraxImage Dongcheng Lantheus Acrotech Biopharma. Progenics Pharmaceuticals International Isotopes
Related Reports
18 Mar 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
